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Abstract
 
At the site of contact between T cells and antigen-presenting cells (APCs), T cell receptor
(TCR)–peptide–major histocompatibility complex (MHC) interaction is intensified by interac-
tions between other molecules, notably by CD28 and lymphocyte function-associated antigen
1 (LFA-1) on T cells interacting with B7 (B7-1 and B7-2), and intracellular adhesion molecule
1 (ICAM-1), respectively, on APCs. Here, we show that during T cell–APC interaction, T
cells rapidly absorb various molecules from APCs onto the cell membrane and then internalize
these molecules. This process is dictated by at least two receptors on T cells, namely CD28 and
TCR molecules. The biological significance of T cell uptake of molecules from APCs is un-
clear. One possibility is that this process may allow activated T cells to move freely from one
APC to another and eventually gain entry into the circulation.
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Introduction
 
T cell interaction with specific peptides bound to MHC
molecules on APCs causes naive T cells to proliferate and
differentiate into effector cells (1, 2). Stimulation of T cells
by APCs is thought to involve at least two signaling events:
signal 1 induced via TCR recognition of peptide–MHC
complexes, and signal 2 elicited by CD28 molecules on T
cells interacting with B7 (B7-1 or B7-2) on APCs. In addi-
tion to CD28–B7, interactions between several other mol-
ecules on T cells and complementary molecules on APCs
appear to augment T cell stimulation (3–6). Whether these
additional interactions, typified by LFA-1 on T cells bind-
ing to intracellular adhesion molecule 1 (ICAM-1)
 
1
 
 on
APCs, activate further signaling pathways or serve as adhe-
sion molecules or both is still controversial.
Interaction between T cells and APCs leads to tight con-
jugate formation and rapid segregation of supramolecular
activation clusters at the T cell contact site (7–11). Lateral
movement of cell surface molecules on T cells into su-
pramolecular activation clusters is known to include TCR,
CD2, CD4/8, LFA-1, and CD28 molecules, and may ap-
ply to a variety of other molecules. Although the individual
binding affinities involved in T–APC molecular interac-
tions are thought to be low, the overall avidity of these in-
teractions at the site of cell–cell contact is presumably very
high and may serve to potentiate both the strength and du-
ration of T cell signaling.
The formation of tight conjugates between T cells and
APCs raises the question of how these cells subsequently
disengage themselves, and whether the cells retain or ex-
change their respective cell surface molecules. On this latter
point, there is extensive literature documenting that T cells
can absorb various molecules, especially MHC and Ig mol-
ecules, from APCs. Studies in the early 1970s demonstrated
that alloreactive T blast cells generated during a graft-ver-
sus-host reaction in vivo expressed Ig molecules (12, 13).
Further studies showed that the Ig molecules were of do-
nor origin, and it was hypothesized that these molecules
represented specific alloantibodies attached to fragments of
host MHC molecules bound to antigen-specific receptors
on T cells. Other in vitro studies confirmed this scenario
and demonstrated that alloreactive blast cells had binding
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 B6, C57BL/6J; DC, dendritic cell;
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specificity for MHC molecules released from APCs by ni-
trogen cavitation (14–16); such binding was antigen spe-
cific. For T cells specific for MHC class II–restricted con-
ventional antigens, absorption of class II molecules from
APCs was shown to require contact with specific antigen
(17, 18). Later studies with bone marrow chimeras indi-
cated that donor-derived thymocytes were able to acquire
host MHC molecules, apparently from thymic epithelial
cells (19, 20). Information on whether T cells can absorb
additional molecules from APCs and other cells is sparse,
although in one study MHC class II–restricted T cell clones
acquired both MHC class I and II molecules from APCs
(21).
In this paper, we have reexamined the capacity of T cells
to absorb cell surface molecules from APCs and defined the
receptor–ligand interactions involved. The data show that
exposure to APCs causes T cells, including naive cells, to
rapidly absorb a variety of cell surface molecules from
APCs. Absorption of these molecules can be mediated by
either TCR–peptide–MHC or by CD28–B7 interaction,
and applies both in vivo and in vitro. Significantly, mole-
cules absorbed to the cell surface are rapidly internalized.
 
Materials and Methods
 
Animals. 
 
C57BL/6J (B6), B10.D2, DBA/2J, and BALB/
cByJ mice were purchased from The Jackson Laboratory.
CD28
 
2
 
/
 
2
 
 (22) and ICAM-1
 
2
 
/
 
2
 
 (23) mice were purchased from
The Jackson Laboratory and maintained at The Scripps Research
Institute. 2C transgenic mice (24) were bred at The Scripps Re-
search Institute. The 2C CD28
 
2
 
/
 
2
 
 mice were generated in our
laboratory. CB-17 SCID mice were purchased from Taconic
Farms. Lewis rats were purchased from Harlan.
 
Cell Lines and Media.  Drosophila
 
 APCs were generated and
maintained as described previously (25). RPMI 1640 medium
supplemented with 10% heat-inactivated FCS, 2 mM glutamine,
5 
 
3
 
 10
 
2
 
5
 
 M 2-ME, and antibiotics was used for T cell culture.
 
Peptides. 
 
QL9 (QLSPFPFDL) and SIYR (SIYRYYGL) pep-
tides were synthesized, purified, and quantitated as described pre-
viously (25, 26). 
 
Drosophila
 
 APCs and dendritic cells (DCs) were
pulsed with the peptides for 2 h at room temperature before use.
 
Cell Purification. 
 
T cells were purified by mAb plus C treat-
ment as described previously (27). For purification of total T cells,
LN cells were treated with a mixture of anti-HSA (J11D) and
anti-IA
 
b
 
 (28-16-8s) mAbs plus a mixture of guinea pig and rabbit
C for 45 min at 37
 
8
 
C. For purification of CD8
 
1
 
 T cells, anti-
CD4 mAb (RL174) was added along with the above mAbs and
C. For purification of 2C CD8
 
1
 
 T cells, positive panning on
anti-CD8 mAb (3.168)-coated plates was performed after mAb
plus C treatment. Rat T cells were enriched by panning LN cells
on mouse anti–rat IgG–coated plates. After 1-h incubation at
4
 
8
 
C, unbound cells were recovered and used. For preparation of
LPS blasts, spleen cells were treated with a mixture of anti-
Thy1.2 (J1j), anti-CD4, and anti-CD8 mAbs plus C and then
cultured for 20 h with LPS (10 
 
m
 
g/ml) followed by Ficoll gradi-
ent separation to remove dead cells. Preactivated T cells were
prepared by culturing purified T cells with PMA (10 nM) and
ionomycin (370 ng/ml) for 14 h. DCs were purified as described
by Inaba et al. (28).
 
Culture Conditions. 
 
For overnight stimulation of 2C T cells
 
(see Fig. 1), purified resting 2C T cells (2 
 
3 
 
10
 
5
 
) were incubated
with transfected 
 
Drosophila
 
 APCs or LPS blasts (8 
 
3
 
 10
 
4
 
) plus 1
 
m
 
M QL9 peptide in a 24-well plate.
For short-term culture, purified resting T cells (2.5 
 
3
 
 10
 
6
 
) or
preactivated T cells (6 
 
3
 
 10
 
5
 
) were mixed with transfected 6 
 
3
 
10
 
5 
 
Drosophila
 
 cells, with or without 1 
 
m
 
M QL9 peptide in a 48-
well plate, centrifuged for 1 min at 120 
 
g
 
, and incubated at 37
 
8
 
C
for 1 h. When DCs were used as APCs, T cells in the above
numbers were incubated with 5 
 
3
 
 10
 
5
 
 DCs with or without 1
 
m
 
M SIYR peptide in a 48-well plate for the indicated period of
time.
For overnight stimulation of rat T cells with mouse DCs, 2 
 
3
 
10
 
5
 
 B-depleted rat T cells were incubated with 2 
 
3
 
 10
 
4
 
 DCs pu-
rified from DBA/2J spleens.
 
Antibodies and Flow Cytometry Analysis.
 
Anti-L
 
d
 
 (30-5-7 [29]),
anti-clonotypic 2C TCR (1B2 [30]), anti-B220 (RA 3-3A1),
anti-V
 
b
 
8.2 (F23.2 [31]), and anti–TCR-
 
b
 
 (H57 [32]) mAbs were
prepared in ascites form. The following mAbs were purchased
from PharMingen: anti–LFA-1 (M17/4); FITC-conjugated anti-
CD8 (53-6.7); FITC-conjugated anti–B7-1 (16-10A1); FITC-con-
jugated anti–rat CD8 (OX-8); PE-conjugated anti–B7-1 (16-10A1);
PE-conjugated anti–B7-2 (GL1); PE-conjugated anti–ICAM-1
(3E2); PE-conjugated anti-K
 
d
 
 (SF1-1.1); PE-conjugated anti-IA
 
b
 
(AF6-120.1); PE-conjugated anti-IA
 
d
 
 (AMS-32.1); PE-conju-
gated anti–rat TCR-
 
a/b
 
 (R73); PE-conjugated anti–human B7-1
(BB1); PE-conjugated anti-HLA (G46-2.6); PE-conjugated
anti–human ICAM-1 (HA58); PE-conjugated streptavidin; and
Cychrome™-conjugated anti–rat CD4 (OX-35). Cy5-conju-
gated anti-CD8 (3.168) mAb was prepared using a Cy5 labeling
kit (Amersham). Biotinylated anti-L
 
d
 
 mAb was prepared in our
laboratory.
Unless stated otherwise, for FACS
 
®
 
 analysis cell surface stain-
ing was performed with FITC-conjugated anti-CD4 or anti-
CD8 mAbs, along with PE-conjugated mAbs specific for other
cell surface markers. After 20-min incubation on ice, cells were
washed and resuspended in FACS
 
®
 
 buffer (1
 
3
 
 PBS, 25 mM
Hepes, 2.5% horse serum) containing 4 
 
m
 
g/ml propidium iodide
(PI). FACSort™ (Becton Dickinson) was used for flow cytome-
try and FACS Vantage™ (Becton Dickinson, CA) was used for
cell sorting. The data shown refer to staining of viable (PI
 
2
 
) cells.
 
In Vivo Stimulation of Rat T Cells. 
 
Doses of 2 
 
3 
 
10
 
7
 
 B cell–
depleted LN T cells from Lewis rats were intravenously injected
into irradiated (350 cGy) CB-17 SCID mice (Taconic Farms).
The activated T cells were recovered from LNs, spleen, and tho-
racic duct lymph (33) 2 or 3 d after injection, and used for cell
surface staining.
 
Reverse Transcription PCR. 
 
Total RNA preparation and
cDNA synthesis were performed as described previously (34). The
conditions used for PCR were as follows: denaturation at 91
 
8
 
C for
30 s, annealing at 55
 
8
 
C for 30 s, and polymerization at 72
 
8
 
C for 1
min for 30 cycles. The primers used for PCR were as follows: (1)
B7-1 sense, ACCTCAATAGACTCTTACTAGT; B7-1 antisense,
CCGCTCTAACTTAGAGGCTG (2); B7-2 sense, ATGCTGT-
TTCCGTGGAGACG; B7-2 antisense, CCGCTCTAACTTA-
GAGGCTG (3); glyceraldehyde 3-phosphate dehydrogenase sense,
TGATGGGTGTGAACCACGAG; and glyceraldehyde 3-phos-
phate dehydrogenase antisense, TCAGTGTAGCCCAAGATGCC.
 
Laser Confocal Microscopy. 
 
PMA and ionomycin–stimulated
or resting T cells were incubated with transfected 
 
Drosophila
 
APCs with or without QL9 for 1 h at 37
 
8
 
C. After incubation,
cells were allowed to attach to poly-
 
l
 
-lysine–coated cover slips
(35) by gravity for 30 min at 4
 
8
 
C. Cells were then sequentially
fixed and permeabilized with 2% paraformaldehyde in PBS for 20 
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min at room temperature and 0.05% saponin in PBS for 10 min
at room temperature (36). The fixed cells were stained with
FITC-conjugated anti–B7-1 and Cy5-conjugated anti-CD8
mAbs. Alternatively, T cells were stained with the mAbs imme-
diately after incubation with 
 
Drosophila
 
 APCs. The mAb-stained
T cells were allowed to adhere to poly-
 
l
 
-lysine coated coverslips
for 30 min at 4
 
8
 
C and the cells were then fixed with 2%
paraformaldehyde in PBS for 20 min at room temperature. The
stained cells were observed under an Axiovert S100 TU™ in-
verted microscope (Zeiss), and LaserSharp™ (Bio-Rad) software
was used for confocal microscope image analysis.
 
Flow Cytometric Analysis of T–APC Conjugate Formation.
 
PMA and ionomycin–stimulated B6 CD8
 
1
 
 T cells (1 
 
3
 
 10
 
5
 
)
were cultured in a final volume of 100 
 
m
 
l with 
 
Drosophila
 
 APCs
(1 
 
3
 
 10
 
5
 
). Cell mixtures were centrifuged briefly (10 s at 200 
 
g
 
)
in 12 
 
3
 
 75 mm tubes (FALCON™ 2054; Becton Dickinson)
and incubated at 37
 
8
 
C in a humidified CO
 
2
 
 incubator for the in-
dicated period of time. After incubation, anti-CD8 mAb (53-6.7,
Cy5) was added for 20 min at 4
 
8
 
C. After staining, T–APC conju-
gates were FACS
 
®
 
 analyzed. T cells and 
 
Drosophila
 
 APCs were
easily distinguished on the basis of side scatter.
 
Results
 
T Cell Absorption of B7 Molecules from Drosophila APCs.
 
As reported previously, primary responses of 2C TCR
transgenic CD8
 
1
 
 cells to H2-L
 
d
 
–restricted QL9 peptide
can be elicited by L
 
d
 
-transfected 
 
Drosophila
 
 cells, but only
when these cells are cotransfected with either B7 (B7-1 or
B7-2) or ICAM-1 molecules (abbreviated L
 
d
 
.B7 and
L
 
d
 
.ICAM-1 Dros. APCs, respectively [25]). With high
concentrations of QL9 peptide, L
 
d
 
.B7 and L
 
d
 
.ICAM-1
Dros. APCs both elicit strong and equivalent 2C CD8
 
1
 
proliferative responses, even though only B7 and not
ICAM-1 is viewed as a classic costimulatory molecule. At
low concentrations of peptide, 2C proliferative responses
are very low unless L
 
d
 
 Dros. APCs coexpress both B7 and
ICAM-1, implying that these two molecules behave syner-
gistically.
Using FACS
 
®
 
 analysis, we examined CD28 and B7 ex-
pression on 2C cells after overnight culture with Dros.
APCs plus QL9 peptide; exposure to a mixture of cross-
linked anti-TCR plus anti-CD28 mAbs was used as a con-
trol. Before culture, cell surface expression on resting 2C
cells was low but significant for CD28 and B7-2 and unde-
tectable for B7-1 (Fig. 1 A).
After culture with L
 
d
 
.ICAM-1 Dros. APCs plus QL9,
expression of CD28 on 2C cells increased considerably,
whereas expression of B7-1 and B7-2 remained as low as
on naive 2C cells (Fig. 1 B); essentially similar findings ap-
plied after mAb-induced TCR/CD28 ligation. The results
were quite different after culture with L
 
d
 
.B7 APCs. With
these APCs, expression of CD28 on 2C cells remained low
or was reduced, whereas B7 expression increased to high
levels. The striking finding was that incubation with L
 
d
 
.B7-1
Dros. APCs led to marked upregulation of B7-1 on 2C
cells but no change in B7-2. Conversely, only B7-2 and
not B7-1 upregulation followed incubation of 2C cells
with L
 
d
 
.B7-2 Dros. APCs. As levels of B7-1 and B7-2
mRNA in 2C cells in these two situations were not ele-
vated relative to resting 2C cells (Fig. 1 C), the appearance
Figure 1. Expression of B7-1
and B7-2 on 2C CD81 cells cul-
tured with Dros. APCs. (A) Sur-
face staining of purified resting
2C CD81 T cells. Cells were
stained with PE-conjugated
anti-CD28, anti–B7-1, and
anti–B7-2 specific mAbs. Iso-
type control staining is shown as
a dotted line and staining with
mAbs as a solid line. (B) Surface
staining of 2C CD81 cells after
overnight culture with the indi-
cated Dros. APCs loaded with 1
mM QL9 peptide. After culture
the cells were stained for CD8
and for the markers indicated.
The data refer to staining of
gated CD81 cells. Dros. APCs
were gated out on the basis of
their CD82 phenotype and their
pattern of forward and side scat-
ter. (C) Expression of B7-1 and
B7-2 mRNA by 2C cells before
and after culture with Dros.
APCs plus QL9 peptide. After
culture 2C cells were depleted
of Dros. APCs by sequential
Percoll and Ficoll gradient cen-
trifugation. Relative levels of mRNA were measured by semiquantitative reverse transcription PCR analysis. (D) Surface staining of 2C T cells after
overnight culture with LPS-stimulated BALB/c (H2d) B cell blasts.1140 T Cells Can Absorb Cell Surface Molecules from APCs
of B7 on 2C cells appeared to reflect absorption from the
APCs rather than de novo synthesis. In agreement with this
idea, culturing 2C cells with QL9 peptide plus Ld1 LPS
blasts, i.e., APCs expressing moderate amounts of both B7-1
and B7-2, led to enhanced staining of both molecules on
2C cells (Fig. 1 D). Three mechanisms could account for
the apparent absorption of B7 from APCs: (1) direct bind-
ing of B7 to CD28, (2) TCR-mediated binding of Ld–QL9
complexes physically linked to B7, e.g., on membrane ves-
icles, and (3) nonspecific absorption.
Absorption Via CD28.  To examine the role of CD28,
normal CD281 versus CD282/2 T cells prepared from nor-
mal (nontransgenic) B6 mice were cultured with Ld.B7-1
Dros. APC (without peptide) for 1 h before staining and
FACS® analysis. B7-1, rather than B7-2, transfectants were
chosen because of the negligible background expression of
B7-1 on normal T cells. With normal resting CD281 B6 T
cells, culture with Ld.B7-1 Dros. APCs induced clear ex-
pression of B7-1 on the T cells accompanied by downregu-
lation of CD28 (Fig. 2 A). Correlating with the higher ini-
tial levels of CD28 on CD41 cells than CD81 cells,
“uptake” of B7-1 by resting T cells was higher on CD41
cells than CD81 cells. Significantly, in marked contrast to
normal B6 T cells, incubating resting CD282/2 T cells
with Ld.B7-1 Dros. APCs failed to cause B7-1 expression
on either CD41 or CD81 cells (Fig. 2 A). Thus, T cell up-
take of B7-1 was CD28 dependent.
Essentially similar findings applied to activated T cells,
e.g., to B6 T cells precultured overnight with PMA plus
ionomycin (Fig. 2 B). The main difference with these T
blast cells was that as manifested by mean fluorescence in-
tensity (MFI), uptake of B7-1 was substantially higher than
with resting T cells, especially for CD81 cells; for CD81
cells, this finding correlated with higher CD28 expression
on activated cells rather than resting CD81 cells. As with
resting T cells, B7-1 uptake by CD282/2 activated T cells
was minimal, though detectable; whether or not the resid-
ual uptake of B7-1 is mediated via CTL-associated antigen
4 has yet to be tested.
Uptake of Ld and other molecules from Dros. APCs is
shown in Fig. 3. When activated CD281 B6 CD81 cells
were incubated with B7-11 APCs (either Ld.B7-1 Dros.
APCs [not shown] or Ld.B7-1.ICAM-1 Dros. APCs, Fig. 3
A, right), the T cells stained positive for both Ld and B7-1;
by contrast, with CD282/2 B6 cells, the T cells were nega-
tive for both Ld and B7-1. Thus, the presence of CD28 on
the T cells allowed these cells to absorb both Ld and B7-1,
presumably in the form of membrane vesicles containing
these two molecules. Significantly, the uptake of Ld by
CD281 T cells only occurred when Dros. APCs coex-
pressed both Ld and B7 (B7-1). Thus, no uptake of Ld oc-
curred when CD281 cells were incubated with B72 APCs,
i.e., with Ld Dros. APCs (not shown) or Ld.ICAM-1 Dros.
APCs (Fig. 3 A, left).
The above findings suggested that CD28 interaction with
B7-1 on Dros. APCs might enable the T cells to absorb any
molecule that was coexpressed on the APCs, i.e., any mole-
cule that was physically associated with B7-1 on the APC
cell membrane, e.g., ICAM-1 on Ld.B7-1.ICAM-1 Dros.
APCs. Testing ICAM-1 uptake by normal T cells was not
feasible because of the high constitutive expression of
ICAM-1 on T cells (Fig. 3 A). However, activated T cells
from ICAM-12/2 mice (CD281ICAM-12/2 T cells) be-
came strongly ICAM-11 (and Ld1B7-11) after incubation
with Ld.B7-1.ICAM-1 Dros. APCs (Fig. 3 B, right). Bear-
ing in mind that T cells express LFA-1, the principal recep-
tor for ICAM-1 (37, 38), it was notable that no T cell up-
take of ICAM-1 occurred with Ld.ICAM-1 Dros. APCs
(Fig. 3 B, left). Thus, the uptake of ICAM-1 from Ld.B7-
1.ICAM-1 Dros. APCs appeared to be controlled solely by
CD28–B7-1 interaction and not by LFA-1–ICAM-1 inter-
action. Nevertheless, uptake of ICAM-1 (and Ld) from
Ld.B7-1.ICAM-1 Dros. APCs was partially blocked by
anti–LFA-1 mAb (Fig. 3 B, right). Hence LFA-1–ICAM-1
Figure 2. CD28-dependent absorption of B7-1 molecules by T cells
after incubation with Dros. APCs. Resting (A) and preactivated (B) puri-
fied T cells prepared from normal B6 (CD281) or CD282/2 B6 mice
were surface stained for CD28 and B7-1 before and after incubation for 1 h
at 378C with Ld.B7-1 Dros. APCs. Stained cells were examined by flow
cytometry. The data show staining on gated CD41 and CD81 cells; con-
taminating Dros. APCs were excluded on the basis of forward and side
scatter and by CD4 or CD8 mAb staining. Dashed lines refer to staining
with an irrelevant isotype-matched control mAb.1141 Hwang et al.
interaction was perhaps too weak to cause direct binding
and uptake of ICAM-1, but was nevertheless able to stabi-
lize CD28-mediated binding of B7-1 plus ICAM-1.
Studies with Dros. APCs expressing human (h)ICAM-1
and hB7-1 showed that B7-dependent uptake of ICAM-1
by T cells was not a property restricted to ICAM-12/2 T
cells. Thus, incubating activated normal CD281 B6 CD81
cells with HLA class I.hB7-1.hICAM-1 Dros. APCs caused
T cell uptake of all three molecules from the APCs (Fig. 3
C). Class I expression on APCs was not essential for uptake
because activated CD281, but not CD282/2, B6 T cells ab-
sorbed both MHC class II IAd and B7-1 (mouse) from
IAd.B7-1 Dros. APCs (Fig. 3 D).
It should be emphasized that removal of cell surface mol-
ecules from Dros. APCs by T cells caused no apparent in-
jury to the APCs. Thus, after the short-term culture was
used, the Dros. APCs remained fully viable in terms of PI
exclusion.
The above data indicate that CD28–B7 interaction can
lead to T cell absorption of a wide range of molecules from
B71 APCs. LFA-1–ICAM-1 interaction is less important,
but can stabilize CD28-mediated absorption. The role of
TCR–peptide–MHC interaction is discussed below.
Absorption Via the TCR.  In the above experiments, the
fact that normal polyclonal (nontransgenic) T cells were
used made it unlikely that CD28-dependent absorption of
B7 (and other molecules) involved the TCR. To seek di-
rect evidence on the role of TCR molecules, 2C CD81
cells were incubated with Ld.B7-1 Dros. APCs with or
without QL9 peptide for 1 h. To avoid CD28-dependent
absorption, CD282/2 2C cells were used. The key finding
here was that after culture with Ld.B7-1 Dros. APCs plus
QL9 peptide, CD282/2 2C cells stained strongly for both
Ld and B7-1 (Fig. 4 A). Uptake of these molecules applied
to both resting and activated CD282/2 2C cells, and was
not seen in the absence of QL9 peptide. Significantly, stain-
ing for Ld and B7-1 on CD282/2 2C cells was totally inhib-
ited by adding anticlonotypic 1B2 mAb to the cultures. Ad-
dition of the Vb8.2-specific F23.2 mAb to 2C (Vb8.21)
cells was ineffective. Absorption of Ld and B7-1 molecules
was thus TCR (and peptide) dependent and CD28 inde-
pendent.
With resting cells, TCR-mediated uptake of Ld and B7-1
molecules from Dros. APCs was also apparent with CD281
2C cells (Fig. 4 B). With these cells, absorption of Ld and
B7-1 from Ld.B7-1 APCs was low, although significant, in
the absence of QL9 peptide (reflecting minimal CD28-medi-
ated uptake), but prominent in the presence of QL9 pep-
tide; as with CD282/2 2C cells, peptide-dependent uptake
of Ld and B7-1 molecules was blocked by 1B2 mAb. The
results with activated CD281 2C cells were less clear cut.
With these cells, CD28-mediated uptake was prominent
and led to strong staining for Ld and B7-1 after culture with
Dros. APCs in the absence of QL9 peptide; significantly,
this nonantigen-specific uptake was not inhibited by 1B2
mAb. With addition of QL9 peptide, uptake of Ld and B7-1
by activated CD281 2C cells increased only slightly (relative
to cells cultured with APCs without peptide) and was not
efficiently blocked by 1B2 mAb.
Absorption at the APC Level.  As expected, T cell ab-
sorption of B7 from Dros. APCs led to a significant (10–
20%) reduction of B7 expression on viable (PI2) APCs (data
not shown). Significantly, staining of APCs revealed no evi-
dence that B71 Dros. APCs could absorb CD28 from T
cells (data not shown). Likewise, when cultured with QL9
peptide, Ld1 Dros. APC failed to absorb TCR from 2C
CD81 cells. Thus, for both CD28- and TCR-mediated ab-
sorption, the transfer of molecules from APCs to T cells ap-
peared to be unidirectional.
Absorption from DCs.  As with transfected Dros. cells, T
cells were able to absorb B7 and other molecules from con-
Figure 3. CD28-dependent T cell absorption of various cell surface
molecules from Dros. APCs. Preactivated CD81 cells prepared from nor-
mal B6 (A, C, and D), CD282/2 B6 (A and D), or ICAM-12/2 B6 mice
(B) were cultured with or without M17/4 anti–LFA-1 mAb (15 mg/ml)
or an isotype-matched control (Cont.) mAb (anti-B220) with Dros.
APCs expressing various mouse or human (h) cell surface molecules
(Ld.ICAM-1 and Ld.B7-1.ICAM-1, A and B; HLA.hB7-1.hICAM-1, C;
and IAd.B7-1, for 1 h, D) and then stained for the markers indicated;
staining of T cells before culture is shown as a control. (B) An anti-B220
mAb was used as a control. In other experiments, no inhibition was seen
with mAbs specific for CD8, CD27, and TCR-b. The data show staining
on gated CD81 cells.1142 T Cells Can Absorb Cell Surface Molecules from APCs
ventional APCs, i.e., from purified DCs. This applied to
both CD28-dependent and TCR-dependent absorption
(Fig. 5). CD28-dependent absorption by preactivated CD281
versus CD282/2 normal (nontransgenic) B6 CD81 cells af-
ter culture with syngeneic B6 (H2b) DCs is illustrated in
Fig. 5 A. Before culture with DCs, the activated T cells
showed no detectable expression of B7-1 or MHC class II
IAb but strong expression of class I Kb. After culture for 1 h
with DCs, CD281 T cells showed clearly significant expres-
sion of B7-1, and strong expression of IAb; high Kb expres-
sion remained unchanged. However, with 1 h culture of
CD282/2 T cells, B7-1 expression on these cells was barely
detectable and IAb expression was much reduced, i.e., z10-
fold lower than on CD281 T cells. These data confirm that
B7 (and class II) absorption by activated T cells is largely a
reflection of CD28–B7 interaction. Nevertheless, the find-
ing that class II expression on DC-cultured CD282/2 T
cells was low rather than absent suggests that class II absorp-
tion also involved other molecules.
To examine TCR-dependent absorption from DCs, we
used B6 CD282/2 2C CD81 cells and B6 DCs. Here, we
used the fact that in addition to recognizing QL9/Ld, the
2C TCR also has specificity for SIYR peptide plus Kb (B6;
see Materials and Methods). When resting CD282/2 2C
cells (B6, H2b) were incubated for 1 h (not shown) or 3 h
(Fig. 5 B) with syngeneic B6 DCs without exogenous pep-
tide, the 2C cells stained negative for B7-1 (and also IAd and
Ld), but showed low, significant expression of IAb (com-
pared with undetectable IAb expression on the cells before
culture). However, after culture with B6 DCs in the pres-
ence of SIYR peptide, B7-1 expression on 2C cells was
clearly apparent and IAb expression increased by z10-fold.
Control staining for Ld and IAd remained negative. These
findings imply that culturing CD282/2 2C cells with B6
DCs led to peptide-dependent uptake of both B7-1 and IAb
from the DCs. Thus, uptake of these molecules appeared to
be TCR dependent and CD28 independent.
In Vivo Absorption.  To examine whether T cell absorp-
tion of B7-1 (and other) molecules occurs under physiolog-
ical conditions, we tested the capacity of rat T cells to ac-
quire mouse B7-1 after transfer to irradiated SCID mice.
The advantage of this rat to mouse system is that rat (r) and
mouse (m) B7-1, 2 are serologically distinct, thus enabling
us to detect whether rat T cells can absorb mB7. In prelimi-
Figure 4. TCR-dependent uptake of B7-1 and Ld from Dros. APCs by CD282/2 (A) versus CD281 (B) 2C CD81 cells. Resting or preactivated
CD81 2C cells (B6 background) were incubated with Ld.B7-1 Dros. APCs with or without QL9 peptide (1 mM) and then stained for B7-1 and Ld ex-
pression. Some cultures were supplemented with 1B2 or F23.2 (anti-Vb8.2) mAb (0.25% ascites fluid). Staining of T cells before culture is shown as a
control. The data show staining on gated CD81 cells.1143 Hwang et al.
nary experiments, culturing purified naive Lewis rat T cells
(a mixture of CD41 and CD81 cells) with mouse (DBA/2,
H2d) DCs for 3 h (not shown) or 20 h (Fig. 6 A) in vitro led
to significant absorption of mB7-1, mB7-2, and mICAM-1
and marginal absorption of mKd. Staining for these four
molecules was negative when rat T cells were cultured
alone or with PMA and ionomycin. Similar absorption of
mouse molecules by rat T cells occurred when rat T cells
were injected intravenously into irradiated (350 cGy) SCID
(H2d) mice (Fig. 6 B). Thus, when the rat cells were recov-
ered from spleen or LNs of the SCID hosts 2–3 d later,
CD41 and CD81 rat T cells (mostly blast cells) showed sig-
nificant expression of mB7-1, mB7-2, mICAM-1, and
mKd. Interestingly, absorption of these molecules was unde-
tectable on circulating cells, i.e., on rat T cells recovered
from thoracic duct lymph.
Fate of Absorbed Molecules.  In agreement with prior
findings on transfected Chinese hamster ovary cells as APCs
(39), culturing preactivated B6 CD281 mouse T cells with
B7-11 Dros. APCs in the absence of peptide led to promi-
nent conjugate formation within 10 min (Fig. 7 A, top).
Significantly, conjugate formation was much lower with
CD282/2 than CD281 T cells. With B72 APCs, e.g.,
Ld.ICAM-1 Dros. cells, conjugate formation was low with
both CD281 and CD282/2 T cells (Fig. 7 A and data not
shown). These findings imply that CD28-dependent uptake
of B7 from APCs is a consequence of initial CD28–B7-
dependent T–APC adhesion.
Cell-sorting experiments demonstrated that the absorbed
B7-1 molecules found on T cells after short-term culture
with B7-11 APCs in vitro disappeared rapidly from the cell
surface. In the experiment shown in Fig. 7 A, bottom, pre-
activated normal B6 CD81 cells were first cultured at 378C
with Ld.B7-1 Dros. APCs (without peptide). After 1 h,
CD81 cells in the cultures were purified by cell sorting and
then cultured alone, i.e., without Dros. APCs. Staining ali-
Figure 5. T cell absorption of surface molecules from DCs. (A) Preac-
tivated CD281 or CD282/2 B6 CD81 cells were cultured for 1 h with
purified normal B6 DCs, then treated with EDTA (1 mM) to disrupt T–DC
contact and stained for expression of the markers shown. (B) Resting
CD282/2 2C CD81 cells were incubated for 3 h with B6 DCs with or
without SIYR peptide (1 mM) and then stained for the markers indicated.
As controls, T cells were stained before culture. The data show staining
on gated CD81 cells. Figure 6. Transfer of cell surface molecules from mouse APCs to rat T
cells. (A) Purified resting Lewis rat T cells were cultured for 20 h with
purified DBA/2 (H2d) DCs without peptide, treated with EDTA (see the
legend to Fig. 5), and then stained for the markers shown. The data show
staining on gated rCD81 cells; staining of fresh T cells and T cells cul-
tured with PMA and ionomycin is shown as a control. (B) Purified rat T
cells were transferred to irradiated SCID mice, recovered from spleen,
LN, or thoracic duct lymph 3 d later, and stained for the markers indi-
cated. These data show staining on gated rCD41 and rCD81 cells.1144 T Cells Can Absorb Cell Surface Molecules from APCs
quots of these T cells at intervals showed that the MFI of
B7-1 staining declined rapidly in culture and reached very
low levels within 4–5 h (80–90% decrease in MFI).
The rapid disappearance of B7-1 from the cell surface
could either reflect internalization or external shedding. To
investigate the first possibility, the cells were examined by
confocal microscopy. Here, preactivated normal CD281
versus CD282/2 CD81 cells were incubated with Ld.B7-1
Dros. APCs (without peptide) for 1 h, then allowed to bind
to coverslips after fixation and staining for CD8 (blue) and
B7-1 (green; Fig. 7 B, top). Nomarski images of the cells are
shown in the left of each panel. For CD281 T cells, exam-
ining the stained cells by confocal microscopy (right)
showed discrete punctate staining for B7-1 not only on the
cell surface, but throughout the cytoplasm. Representative
internal staining of two individual cells is shown; the pattern
of ring staining for CD8 denotes the cell surface. In marked
contrast, CD282/2 CD81 cells showed no staining for B7-1,
either internally or on the cell surface. In other experiments,
intracellular staining of nondisrupted conjugates formed be-
tween activated CD281 T cells and B7-11 Dros. APCs on
coverslips showed conspicuous internal staining for B7-1 in
T cells (Fig. 7 B, bottom). Hence, T cell internalization of
B7-1 from APCs could occur under conditions where T
cells and APCs were not physically disrupted.
The above data refer to CD28-mediated absorption of
B7-1 by preactivated normal B6 CD81 cells. Essentially
identical findings occurred with 2C CD81 cells (Fig. 7 C).
Thus, with preactivated (top) and resting (bottom) 2C cells,
incubation with Ld.B7-1 Dros. APCs without peptide led to
clear surface and internal staining for B7-1 with CD281
cells but no staining with CD282/2 cells. However, when
CD282/2 2C cells were incubated with Ld.B7-1 Dros.
APCs in the presence of QL9 peptide, both internal and ex-
Figure 7. Fate of B7-1 mole-
cules absorbed by T cells. (A)
Top, Preactivated B6 CD81 cells
were cultured with the indicated
Dros. APCs in the absence of
peptide for 10 min. T–APC con-
jugates were detected by FACS®
analysis on the basis of combined
CD8 expression and high side
scatter (SSC). Percentage of
CD81 cells forming the conju-
gates with Dros. APCs was plot-
ted. Bottom, Preactivated B6
CD81 cells were cultured with
Ld.B7-1 Dros. APCs for 1 h, then
depleted of APCs by cell sorting
for CD8 expression and cultured
alone (at 378C) for the intervals
indicated before surface staining
for B7-1. (B) Preactivated
CD281 and CD282/2 B6 CD81
cells were incubated for 1 h with
Ld.B7-1 Dros. APCs (without
peptide), fixed, and stained for
B7-1 (green, FITC) and CD8
(blue, Cy5). Two experiments
are shown: (top) after culture in
normal medium, cells were dis-
rupted and then fixed and stained
after adherence to poly-l-lysine–
coated coverslips; (bottom) cells
were cultured initially on poly-l-
lysine–coated coverslips and then
fixed and stained without disrup-
tion. (C) Preactivated or resting
CD281 and CD282/2 CD81 2C
cells were incubated for 1 h with
Ld.B7-1 Dros. APCs with or
without QL9 peptide, stained for
B7-1 and CD8 as in B, and then
fixed. The data in the right panels
show representative surface and
intracellular staining seen in mul-
tiple slices of two representative
cells as detected by confocal
microscopy (see Materials and
Methods). Nomarski images of the cells are shown on the left. In other experiments, staining the cells for B7 with two different fluorochromes showed that
B7 staining before permeabilization was restricted to the cell membrane, whereas B7 staining after permeabilization was largely intracellular.1145 Hwang et al.
ternal staining for B7-1 was clearly apparent. Hence inter-
nalization of absorbed B7-1 applied not only to CD28-
dependent absorption but also to TCR-dependent uptake.
Discussion
As mentioned in the Introduction, there are several re-
ports that T–APC interaction leads to the appearance of
APC-derived molecules on T cells. Although this process
was shown to be antigen specific, the mechanisms and re-
ceptor–ligand interactions involved were not resolved. As
shown here, T cell uptake of molecules from APCs occurs
very rapidly (#1 h), applies to a wide range of molecules
on APCs, and is controlled by at least two different recep-
tors on T cells, namely CD28 and TCRs.
The role of CD28 was defined by culturing normal
(nontransgenic) CD281 versus CD282/2 T cells with B71
Dros. APCs or B6 DCs. With CD281 T cells, short-term
culture with APCs in the absence of specific antigen led to
rapid T cell uptake of B7 (B7-1) and other molecules from
the APCs. By contrast, with CD282/2 T cells uptake of
these molecules was undetectable with Dros. APCs and
very low (though significant) with DCs. Hence, for Dros.
APCs, uptake of B7 and other molecules by T cells ap-
peared to be solely under the control of CD28.
The extent of T cell B7 absorption via CD28 correlated
closely with the level of CD28 on T cells. Thus, with rest-
ing T cells, the stronger absorption of B7 by CD41 cells
than CD81 cells correlated with substantially higher CD28
expression on CD41 cells than CD81 cells. Likewise, the
marked increase in CD28 expression found on activated
CD41 and CD81 cells led to a corresponding increase in
B7 uptake from APCs. It is of interest that both for resting
and activated T cells, uptake of B7 from APCs was associ-
ated with a marked decrease in CD28 staining. The sim-
plest explanation for this finding is that the CD28 epitopes
recognized by anti-CD28 mAb are occluded after binding
of B7 to CD28.
The observation that nonantigen-specific T cell uptake
of molecules from APCs is primarily under the control of
CD28 is surprising because CD28 is generally viewed as a
signaling molecule (3, 40–42). Evidence that CD28 can act
as an adhesion molecule is sparse, although CD28-transfec-
tion of Chinese hamster ovary cells was shown to induce
B7-specific adhesion to B cells (39). As cell–cell adhesion is
thought to be largely under the control of integrins such as
LFA-1 (43, 44), T cell uptake of APC-derived molecules
would be expected to involve LFA-1–ICAM-1 interaction.
However, this was not the case. Thus, even with activated
T cells, uptake of ICAM-1 from Dros. APCs was undetect-
able unless these cells coexpressed B7. Nevertheless, it is of
interest that CD28-dependent uptake of ICAM-1 from
B71 APCs was partially reduced by anti–LFA-1 mAb. This
finding implies that LFA-1 can augment or stabilize T cell
uptake of ICAM-1 from APCs, but only when ICAM-1 is
absorbed indirectly via CD28–B7 interaction. For uptake
of molecules from APC, the affinity and/or avidity of LFA-
1–ICAM-1 interaction thus appeared to be substantially
weaker than for CD28–B7 interaction. The data on
nonantigen-specific conjugate formation are consistent
with this notion. Thus, with activated T cells, prominent
conjugate formation was seen only with CD281 T cells and
B71 APCs (Fig. 7 A); with CD282/2 (LFA-11) T cells,
conjugate formation was low with both B71 ICAM-12
and B72ICAM-11 APCs, implying poor conjugate forma-
tion via LFA-1–ICAM-1 interaction.
It should be emphasized that CD28-mediated absorption
of molecules from APCs also applied to DCs, i.e., to con-
ventional APCs. However, with these APCs, absorption
was not totally CD28 dependent. Thus, short-term culture
of CD282/2 B6 CD81 cells with normal B6 DCs led to
low but significant uptake of IA molecules. This uptake
was z10-fold lower than with CD281 CD81 cells. These
findings with DCs indicate that nonantigen-specific uptake
of APC-derived molecules by T cells is not an exclusive
property of CD28–B7 interaction. Apparently other, as yet
unknown, receptor–ligand interactions are also involved.
Demonstrating TCR-mediated uptake of molecules
from APCs by TCR transgenic T cells was complicated by
concomitant absorption via CD28–B7 interaction. This
problem was avoided by using CD282/2 T cells. Thus,
when either resting or activated CD282/2 2C CD81 cells
were cultured with Ld.B7-1 Dros. APCs, T cell uptake of
these two molecules was conspicuous providing specific
QL9 peptide was added to the cultures. By contrast, in the
absence of peptide, uptake of these molecules by 2C cells
was very low or undetectable. Confirming that uptake was
TCR mediated, QL9-dependent 2C absorption of both Ld
and B7-1 from Dros. APCs was almost totally inhibited by
1B2 anticlonotypic mAb. Curiously, no inhibition was
seen with Vb-specific F23.2 mAb, presumably indicating
that the TCR epitopes detected by this mAb are distant
from the sites involved in TCR–peptide–MHC interac-
tion.
With CD281 2C cells, TCR-mediated absorption from
APCs by activated 2C cells was largely obscured by con-
comitant strong CD28-mediated absorption. However, this
problem was much less noticeable with resting CD281 2C
cells. With these cells, CD28-mediated absorption was lim-
ited (reflecting the low level of CD28 on resting CD81
cells) and led to only low nonantigen-specific absorption
when 2C cells were cultured with Dros. APCs in the ab-
sence of peptide. However, with addition of QL9 peptide,
uptake of Ld and other molecules from APCs was conspic-
uous. As with CD282/2 2C cells, peptide-dependent up-
take of these molecules by resting CD281 2C cells was
blocked by 1B2 mAb.
It is notable that both for CD28–B7 and TCR–peptide–
MHC interaction, T cell absorption from APCs applied
not only to the particular ligand recognized, but to a spec-
trum of other molecules on APCs. As such binding applied
with several types of APC (Dros. cells, DCs, and LPS
blasts), and was also conspicuous under in vivo conditions
(in rat to mouse chimeras), artifact seems unlikely. How-
ever, precisely how molecules are transferred from APCs to
T cells is still unclear. Perhaps the simplest idea is that T1146 T Cells Can Absorb Cell Surface Molecules from APCs
cells bind APC-derived molecules in the form of detached
membrane fragments as vesicles. Against this idea we have
seen only minimal CD28–B7-mediated uptake of APC-
derived molecules when T cells and APCs are separated by
a semipermeable (0.2 mM) membrane, or when T cells are
incubated with either APC sonnicates or supernatants from
live APCs (our unpublished data). These findings suggest
that T cell absorption of molecules from APCs may require
direct cell–cell contact (see below). Here it should be men-
tioned that we have observed only very limited absorption
of B7 from paraformaldehyde-fixed APCs (our unpub-
lished data), which suggests that B7 absorption involves a
dynamic process and requires a normal APC membrane.
An obvious concern is that T cell binding of APC-derived
molecules reflects the sheer forces involved in physically
separating T cells and APCs for FACS® analysis. This possi-
bility is unlikely because at the end of the short-term cul-
ture period used (1 h), microscopic examination of T–APC
cultures revealed surprisingly little evidence of aggregate
formation, especially with resting T cells, and the cells were
easily dispersed. It is also worth noting that at least for
Dros. APCs, physically separating these cells from T cells
did not obviously impair APC viability, implying that sepa-
rating the cells did not induce “holes” in the APC mem-
brane, even though contact with T cells removed 10–20%
of B7 molecules from the cells.
With regard to the fate of the absorbed material, short-
term culture of T cells with APCs followed by culture un-
der APC-free conditions showed that most of the material
absorbed by T cells disappeared from the cell surface within
3 h. Using confocal microscopy, the key observation was
that at least for B7, the absorbed material was internalized,
both for TCR- and CD28-mediated absorption. This in-
ternalization also occurred when T cells and APCs were
not physically disrupted. With regard to other molecules,
in recent studies we have observed peptide-dependent in-
ternalization of Ld molecules when 2C cells are incubated
with Dros. APCs transfected with green-fluorescent pro-
tein–labeled Ld molecules (GFP.Ld; 45). As for B7-1, such
internalization of Ld molecules by 2C cells is apparent un-
der conditions where T–APC conjugates are not disrupted.
These latter studies have shown that internalized Ld mole-
cules are rapidly degraded in lysosomes. Whether the same
applies to B7 has yet to be examined. For GFP.Ld, it is no-
table that T cell internalization is almost entirely restricted
to T cells forming conjugates with APCs (our unpublished
data). This finding provides further support for the view
that transfer of molecules from APCs to T cells requires di-
rect cell contact (see above).
With regard to biological significance, it is now well
documented that T–APC interaction can lead to rapid in-
ternalization of the TCR (46, 47). This process is thought
to allow TCR molecules to dissociate from MHC–peptide
complexes, and after recycling to the cell membrane, allow
TCR molecules to engage in serial triggering (47). How-
ever, our finding that TCR internalization is accompanied
by internalization of MHC molecules (presumably as
MHC–peptide complexes) and also of B7 and probably
several other molecules suggests an alternative possibility.
Thus, one purpose of internalization of TCR and various
APC-derived molecules at the site of T–APC contact
could be simply to terminate cell–cell interaction and allow
the cells to dissociate. In favor of this idea, we have found
that T–APC dissociation in culture occurs more slowly
with paraformaldehyde-fixed APCs than with unfixed
APCs (our unpublished data). This finding correlates with
reduced T cell uptake of molecules from fixed APCs. For
T cells, interrupting tight contact with APCs could be cru-
cial for enabling activated T cells to find other APCs and
eventually make their way into the circulation for dissemi-
nation as effector cells. Here, it is of interest that absorption
of mouse molecules by rat T cells transferred to SCID mice
was apparent only in the lymphoid tissues and not in tho-
racic duct lymph.
The notion that T cell internalization of APC-derived
molecules is important for T–APC dissociation has yet to
be proved and several other possibilities need to be consid-
ered. First, based on studies on eye development in insects
(48, 49), it is conceivable that internalization of cell surface
ligands may contribute to intracellular signaling. Whether
this notion is applicable to mammalian cells is unknown.
Second, ingestion of peptide–MHC complexes by T cells
could serve to guard against overstimulation of T cells and
tolerance via exhaustion; consistent with this idea, we have
found that decreased T–APC dissociation observed with
fixed APCs correlates with much higher T proliferative re-
sponses (our unpublished data). Finally, T cell uptake of
peptide–MHC complexes from APCs could also have neg-
ative consequences. Thus, in recent studies we have found
that T cells absorbing peptide–MHC complexes from
APCs can become targets for CTLs (45). Such fratricidal
killing of T cells may contribute to the massive elimination
of T cells found in high dose viral infections (50).
In conclusion, the data in this paper demonstrate that
T–APC interaction can lead T cells to absorb and ingest
various cell surface molecules from APCs. This process is
primarily under the control of CD28–B7 and TCR–pep-
tide–MHC interactions. The biological significance of this
phenomenon is still unclear and will have to await further
investigation.
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